Factor Associated With Mortality in the ICU

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorHospital Departamental de Villavicencio

About this trial

ICU mortality indicates the severity of disease, healthcare quality, and the efficacy of interventions. The severity scores are tools to predict the risk of mortality in the ICU, and the APACHE II score is frequently used for this purpose. However, studies validating the score in Colombia are limited. There is uncertainty about the precision and discrimination capacity of the APACHE II score in a population that varies from the original, with varying diseases, and in a different timeline. The investigators determined to evaluate: 1. Evaluate the rate of mortality in the ICU by type of disease and type of admission. 2. The factors associated with mortality. 3. Validate the performance of the APACHE II score as a predictor of mortality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All adult patients older than 18 admitted to the intensive care unit during the study period.

Disqualifiers

Patients admitted for intermediate care (low therapeutic intervention with a TISS [Therapeutic Intervention Scoring System] - 28 score below 20 points). Patients derived to other institutions.

Trial population

Adult critically ill patients with a high need of support and intervention in the intensive care unit.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Exposure factors

    Other intervention

    Evaluation of factors associated with mortality

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: ICU mortality1 intervention
Group B: ICU survivors1 intervention

Trial outcomes

Primary outcomes

1

Mortality

Dead discharges

Time frame
Within 28 days

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.